IL8 polymorphisms and overall survival in pazopanib- or sunitinib-treated patients with renal cell carcinoma.

Xu, CF; Johnson, T; Garcia-Donas, J; Choueiri, TK; Sternberg, CN; Davis, ID; Bing, N; Deen, KC; Xue, Z; McCann, L; +6 more... Esteban, E; Whittaker, JC; Spraggs, CF; Rodríguez-Antona, C; Pandite, LN; Motzer, RJ; (2015) IL8 polymorphisms and overall survival in pazopanib- or sunitinib-treated patients with renal cell carcinoma. British journal of cancer, 112 (7). pp. 1190-8. ISSN 0007-0920 DOI: https://doi.org/10.1038/bjc.2015.64

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1038/bjc.2015.64

Abstract

Share

Download

Filename: bjc201564a.pdf

Licence: Creative Commons: Attribution-Noncommercial-Share Alike 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar